CXCR inhibitor Kynurenic acid sodium, Purity ≥98%

Cat. No.: X23-10-ZQ706

CXCR inhibitor Kynurenic acid sodium, Purity ≥98%

Synonym: Kynurenic acid sodium salt; 2439-02-3; Kynurenic acid (sodium); Kynurenic Acid Sodium; 4-oxo-1H-quinoline-2-carboxylate; 4-Hydroxyquinoline-2-carboxylic acid sodium salt; CXCR inhibitor

  • CAS Number: 2439-02-3
  • Compound CID: 52974250
Product Size
100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Kynurenic acid sodium targets the chemokine receptors CXCR, which are part of the GPCR family. It targets human endogenous metabolite and NMDA receptor.
Molecular Weight
211.16
Molecular Formula
C10H6NNaO3
Targets
Human endogenous metabolite; NMDA receptor
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Kynurenic acid sodium is utilized to explore the role of the kynurenine pathway in neuroprotection and neurotransmission.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.